SMMT
Summit Therapeutics PLC
17.60$
+2.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.9% | 91.1% | 82.8% | 36.5% | 38.8% | 57.7% | 73.3% | 67.8% | 95.6% | 42.4% | 78.3% | 83.2% | 88.7% | 66.5% | 77.0% | 82.3% | 85.5% | 85.8% | 98.9% | 93.5% | 97.3% | 95.9% | |
| 100.0% | 99.2% | 7.2% | 77.2% | 28.9% | 19.5% | 52.9% | 63.8% | 53.3% | 77.2% | 27.8% | 58.1% | 65.0% | 74.7% | 37.3% | 44.3% | 66.2% | 64.8% | 63.3% | 52.5% | 35.2% | 24.1% | 30.0% | |
| 100.0% | 99.2% | 87.2% | 77.2% | 28.9% | 19.5% | 52.9% | 63.8% | 53.3% | 77.2% | 27.8% | 58.1% | 65.0% | 74.7% | 37.3% | 44.3% | 66.2% | 64.8% | 63.3% | 52.5% | 91.8% | 94.7% | 95.0% | |
| – | 0.6% | 1.4% | 2.1% | 2.1% | 7.7% | 2.3% | 3.9% | 15.0% | 13.3% | 6.0% | 5.2% | 6.4% | 10.1% | 17.2% | 15.7% | 0.4% | 9.9% | 15.1% | 0.9% | 0.4% | 0.1% | – | |
| – | 0.2% | 0.2% | 0.8% | 1.0% | 2.8% | – | – | -1.3% | 7.0% | 0.0% | 14.2% | 1.6% | 0.2% | 0.0% | 0.0% | 0.0% | -15.6% | 8.5% | 1.3% | 1.5% | – | – | |
| – | – | – | – | – | – | – | – | – | 0.5% | 0.6% | 0.3% | 0.2% | 0.2% | 1.1% | 0.8% | 1.5% | 1.7% | 4.1% | 0.9% | – | – | – | |
| – | – | – | 41.8% | 28.0% | – | – | – | – | – | 5.5% | 3.4% | 2.6% | 1.8% | 4.6% | 3.0% | 1.5% | 2.0% | 1.8% | 0.3% | 0.9% | 0.4% | 0.3% | |
| 25.8% | 0.1% | 0.2% | 6.2% | 23.3% | 34.6% | 39.4% | 21.6% | 28.3% | 3.9% | 29.0% | 18.0% | 13.8% | 9.2% | 27.4% | 17.5% | 10.2% | 11.2% | 9.2% | 1.9% | – | – | – | |
| 2.5% | 1.3% | 9.6% | 13.6% | 22.1% | 38.7% | 28.0% | 27.8% | 38.2% | 34.9% | 34.7% | 33.2% | 15.7% | 109.3% | 81.7% | 29.8% | 19.0% | 22.5% | 26.5% | 80.9% | 61.7% | 10.7% | 12.3% | |
| 2.5% | 1.3% | 4.9% | 6.1% | 9.8% | 13.4% | 9.6% | 23.7% | 33.0% | 34.9% | 25.6% | 18.4% | 12.8% | 29.0% | 35.1% | 21.6% | 13.1% | 19.4% | 22.6% | 5.8% | 10.1% | 9.6% | 9.7% | |
| – | 0.4% | 0.5% | 0.3% | 0.5% | 1.0% | – | – | 19.6% | 28.3% | – | – | 14.3% | 10.8% | 23.6% | 0.0% | -0.9% | 0.4% | 1.0% | 3.2% | 1.4% | 0.9% | 0.5% | |
| 23.2% | 0.1% | 3.4% | 4.9% | 5.2% | 4.8% | 1.3% | 6.5% | 33.0% | 31.4% | 4.8% | 18.4% | 12.8% | 10.6% | 16.6% | 7.3% | 4.5% | 6.0% | 3.9% | 0.1% | 1.3% | 1.1% | 2.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 91.3% | 62.3% | – | – | |
| 97.5% | 98.7% | 90.4% | 86.4% | 77.9% | 61.3% | 72.0% | 72.2% | 61.8% | 65.1% | 65.3% | 66.8% | 84.3% | -9.3% | 18.3% | 70.2% | 81.0% | 77.5% | 73.5% | 19.1% | 38.3% | 89.3% | 87.7% | |
| -27.5% | -0.3% | -7.7% | -17.5% | -40.9% | -262.9% | -238.9% | -631.9% | -894.9% | -893.1% | -619.4% | -166.3% | -188.8% | -196.3% | -149.9% | -125.5% | -158.3% | -205.8% | -264.2% | -57.0% | -489.4% | -278.9% | -305.4% | |
| 13,033.6% | 87.3% | 121.0% | 78.4% | 69.0% | 265.7% | 364.6% | 473.9% | 2,907.6% | 228.7% | 170.4% | 135.5% | 165.5% | 131.0% | 85.7% | 108.3% | 43.5% | 92.3% | 109.8% | 35.7% | 385.8% | 206.4% | 134.1% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.